Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1
- PMID: 20797388
- DOI: 10.1016/j.bcp.2010.08.008
Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1
Abstract
OATP1A2 and OATP2B1 are uptake transporters of the human organic anion transporting polypeptide (OATP) family with a broad substrate spectrum including several endogenous compounds as well as drugs such as the antihistaminic drug fexofenadine and HMG-CoA reductase inhibitors. Both transporters are localized in the apical membrane of human enterocytes. Flavonoids, abundantly occurring in plants, have previously been shown to interact with drug metabolizing enzymes and transporters. However, the impact of flavonoids on OATP1A2 and OATP2B1 transport function has not been analyzed in detail. Therefore, HEK293 cell lines stably expressing OATP1A2 and OATP2B1 were used to investigate the influence of the Ginkgo flavonoids apigenin, kaempferol, and quercetin on the transport activity of OATP1A2 and OATP2B1. K(i) values of all three flavonoids determined from Dixon plot analyses using BSP as substrate indicated a competitive inhibition with quercetin as the most potent inhibitor of OATP1A2 (22.0μM) and OATP2B1 (8.7μM) followed by kaempferol (OATP1A2: 25.2μM, OATP2B1: 15.1μM) and apigenin (OATP1A2: 32.4μM OATP2B1: 20.8μM). Apigenin, kaempferol, and quercetin led to a concentration-dependent decrease of the OATP1A2-mediated fexofenadine transport with IC(50) values of 4.3μM, 12.0μM, and 12.6μM, respectively. The OATP1A2- and OATP2B1-mediated transport of atorvastatin was also efficiently inhibited by apigenin (IC(50) for OATP1A2: 9.3μM, OATP2B1: 13.9μM), kaempferol (IC(50) for OATP1A2: 37.3μM, OATP2B1: 20.7μM) and quercetin (IC(50) for OATP1A2: 13.5μM, OATP2B1: 14.1μM). These data indicate that modification of OATP1A2 and OATP2B1 transport activity by apigenin, kaempferol, and quercetin may be a mechanism for food-drug or drug-drug interactions in humans.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Inhibition of hepatic uptake transporters by flavonoids.Eur J Pharm Sci. 2012 May 12;46(1-2):79-85. doi: 10.1016/j.ejps.2012.02.014. Epub 2012 Feb 28. Eur J Pharm Sci. 2012. PMID: 22394605
-
Organic anion transporting polypeptides and organic cation transporter 1 contribute to the cellular uptake of the flavonoid quercetin.Naunyn Schmiedebergs Arch Pharmacol. 2014 Sep;387(9):883-91. doi: 10.1007/s00210-014-1000-6. Epub 2014 Jun 20. Naunyn Schmiedebergs Arch Pharmacol. 2014. PMID: 24947867
-
pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1.Mol Pharm. 2011 Aug 1;8(4):1303-13. doi: 10.1021/mp200103h. Epub 2011 Jul 11. Mol Pharm. 2011. PMID: 21710988
-
Organic anion transporting polypeptide 2B1 - More than a glass-full of drug interactions.Pharmacol Ther. 2019 Apr;196:204-215. doi: 10.1016/j.pharmthera.2018.12.009. Epub 2018 Dec 14. Pharmacol Ther. 2019. PMID: 30557631 Review.
-
Oral drug delivery utilizing intestinal OATP transporters.Adv Drug Deliv Rev. 2012 May 1;64(6):508-14. doi: 10.1016/j.addr.2011.07.007. Epub 2011 Jul 30. Adv Drug Deliv Rev. 2012. PMID: 21824501 Review.
Cited by
-
Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2.AAPS J. 2013 Oct;15(4):1099-108. doi: 10.1208/s12248-013-9515-1. Epub 2013 Aug 6. AAPS J. 2013. PMID: 23918469 Free PMC article.
-
Hepatic Uptake Mechanism of Ophiopogonin D Mediated by Organic Anion Transporting Polypeptides.Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):669-676. doi: 10.1007/s13318-016-0384-8. Eur J Drug Metab Pharmacokinet. 2017. PMID: 27815731
-
Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers.Clin Pharmacol Ther. 2022 Sep;112(3):627-634. doi: 10.1002/cpt.2682. Epub 2022 Jun 29. Clin Pharmacol Ther. 2022. PMID: 35678032 Free PMC article. Clinical Trial.
-
Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers.Eur J Clin Pharmacol. 2018 Jun;74(6):775-783. doi: 10.1007/s00228-018-2436-2. Epub 2018 Feb 26. Eur J Clin Pharmacol. 2018. PMID: 29480324 Clinical Trial.
-
Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.Pharmaceutics. 2021 Jan 19;13(1):124. doi: 10.3390/pharmaceutics13010124. Pharmaceutics. 2021. PMID: 33478035 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources